David Price | CFO |
Nancy Lurker | President and CEO |
Leonard Ross | VP, Finance and CAO |
François Brisebois | Laidlaw |
Andrew D'Silva | B. Riley FBR |
Yi Chen | H.C. Wainwright |
Good morning. My name is Daniel and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharma Fiscal 2018 Fourth Quarter and Full Year Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request.